π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Status
Recruiting
Location
Cancer Center of Guangzhou Medical University
Start Date
2025-06-24
Trial ID
NCT07070479
RATIONALE: Drugs used in chemotherapy, such as S-1 and irinotecan, work in ...
Status
Unknown
Location
Yamamoto Kumiai General Hospital
Start Date
2004-09
Trial ID
NCT00134095
The purpose of this study is to evaluate the efficacy and safety of HR07080...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06383078
Treatments Being Tested
This randomized phase III study compares safety and efficacy of two sequenc...
Status
Suspended
Location
Hokkaido University Hospital (Hokkaido University Graduate School of Medicine / School of Medicine)
Start Date
2006-04
Trial ID
NCT00316745
Treatments Being Tested
To assess the usefulness of irinotecan plus S-1 therapy based on the antitu...
Status
Suspended
Location
Hokkaido University Hospital
Start Date
2004-01
Trial ID
NCT00209664
Treatments Being Tested
The study explores the efficacy and safety of oxaliplatin combined with iri...
Status
Completed
Location
Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2024-08-23
Trial ID
NCT06538623
Treatments Being Tested
This study will evaluate the efficacy and safety of adjuvant therapy with l...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09
Trial ID
NCT06571461
Treatments Being Tested
To assess the usefulness of irinotecan plus S-1 therapy based on the antitu...
Status
Completed
Location
Multiple Locations
Start Date
2000-05
Trial ID
NCT00209638
Treatments Being Tested
The irinotecan and cisplatin combination showed significant anti-tumor acti...
Status
Unknown
Location
Asan Medical Center
Start Date
2008-10
Trial ID
NCT00874328
Treatments Being Tested
A randomized phase II study to compare the efficacy and safety of SLOG or m...
Status
Completed
Location
National Institute of Cancer Research
Start Date
2018-03-26
Trial ID
NCT03443492
Treatments Being Tested